Boston Scientific Rhythmand Neuro — Goodwill, Acquired During Period decreased by 100.0% to $0.00 in Q4 2021 compared to the prior quarter.
Higher values indicate an aggressive M&A strategy to expand the segment's product portfolio or market share.
Represents the amount of goodwill added to the Rhythm and Neuro segment balance sheet resulting from new business acquis...
Used by growth-oriented medical device firms to track the scale of their acquisition-led expansion.
bsx_segment_rhythm_and_neuro_goodwill_acquired_during_period| Q2 '21 | Q3 '21 | Q4 '21 | |
|---|---|---|---|
| Value | $2.00M | $386.00M | $0.00 |
| QoQ Change | — | >999% | -100.0% |